Alma Gold Inc
CNSX:ALMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alma Gold Inc
CNSX:ALMA
|
CA |
|
Tata Coffee Ltd
NSE:TATACOFFEE
|
IN |
|
E
|
Extrawell Pharmaceutical Holdings Ltd
HKEX:858
|
HK |
|
A
|
Ajinomoto (Malaysia) Bhd
KLSE:AJI
|
MY |
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
SA |
|
F
|
Fujian Nanwang Environment Protection Scien-tech Co Ltd
SZSE:301355
|
CN |
|
Banque Saudi Fransi SJSC
SAU:1050
|
SA |
|
J
|
JDC Corp
TSE:1887
|
JP |
|
OS Co Ltd
TSE:9637
|
JP |
|
B
|
Bergenbio ASA
OSE:BGBIO
|
NO |
|
Zealand Pharma A/S
CSE:ZEAL
|
DK |
|
S
|
Shanghai Jin Jiang Capital Co Ltd
HKEX:2006
|
CN |
|
Almawave SpA
MIL:AIW
|
IT |
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
SE |
|
Saudi Real Estate Company SJSC
SAU:4020
|
SA |
|
Greenlam Industries Ltd
NSE:GREENLAM
|
IN |
|
Zhong Yang Technology Co Ltd
TWSE:6668
|
TW |
|
Sajodongaone Co Ltd
KRX:008040
|
KR |
|
I
|
ImmunoGen Inc
XETRA:IMU
|
US |
Income Statement
Earnings Waterfall
Alma Gold Inc
Income Statement
Alma Gold Inc
| Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Operating Income |
(0)
N/A
|
(0)
+44%
|
(0)
+8%
|
(0)
+1%
|
(0)
-32%
|
(1)
-302%
|
(0)
+62%
|
(1)
-36%
|
(1)
+2%
|
|
| Pre-Tax Income | ||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(1)
|
0
|
(1)
|
(1)
|
(2)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
+44%
|
0
N/A
|
0
-22%
|
(1)
N/A
|
(1)
-6%
|
(1)
-33%
|
(2)
-10%
|
(3)
-73%
|
|
| Net Income | ||||||||||
| Income from Continuing Operations |
(0)
|
(0)
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
+44%
|
0
N/A
|
0
-22%
|
(1)
N/A
|
(1)
-6%
|
(1)
-33%
|
(2)
-10%
|
(3)
-73%
|
|
| EPS (Diluted) |
-0.03
N/A
|
-0.02
+33%
|
0
N/A
|
0
N/A
|
-0.05
N/A
|
-0.03
+40%
|
-0.05
-67%
|
-0.05
N/A
|
-0.08
-60%
|
|